Peter DeMuth

Directeur Technique/Scientifique/R&D chez ELICIO THERAPEUTICS, INC.

Fortune : - $ au 31/05/2024

38 ans

Health Technology

Finance

Consumer Services

Postes actifs de Peter DeMuth

Sociétés	Poste	Début	Fin
ELICIO THERAPEUTICS, INC.	Directeur Technique/Scientifique/R&D	01/01/2022	-

Sociétés	Poste	Début	Fin
Elicio Therapeutics, Inc. (Old) Elicio Therapeutics, Inc. (Old) BiotechnologyHealth Technology Elicio Therapeutics, Inc. engages in the development of vaccines for infectious disease and cancer. Its programs focus on a novel lipid nanocapsule platform technology for delivering vaccines in a form mimicking the structure of pathogens to elicit potent immunity in prophylactic and therapeutic settings. The company was founded by Satish Jindal and Darrell Irvine on August 10, 2011 and is headquartered in Cambridge, MA.	Directeur Technique/Scientifique/R&D	01/08/2017	01/06/2023

Massachusetts Institute of Technology	Doctorate Degree
University of Maryland	Undergraduate Degree

Internationale

Etats-Unis

Opérationnelle

Sectorielle

Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Sociétés cotées	1
ELICIO THERAPEUTICS, INC.	Health Technology

Entreprise privées	1
Elicio Therapeutics, Inc. (Old) Elicio Therapeutics, Inc. (Old) BiotechnologyHealth Technology Elicio Therapeutics, Inc. engages in the development of vaccines for infectious disease and cancer. Its programs focus on a novel lipid nanocapsule platform technology for delivering vaccines in a form mimicking the structure of pathogens to elicit potent immunity in prophylactic and therapeutic settings. The company was founded by Satish Jindal and Darrell Irvine on August 10, 2011 and is headquartered in Cambridge, MA.	Health Technology

Entreprise privées

Health Technology